• el
  • en

Introduction of a new drug in Osteoporosis

15 December 2011 | posted in: Announcements, Press Releases

Medical pharmaquality announces the launch of its new drug

Zulgar is a generic alendronate and is indicated in the treatment of osteoporosis.

More specifically Zulgar is a 1st choice treatment for postmenopausal osteoporosis and for the reduction of hip and vertebral fracture risk

Zulgal is launched in the formulation of 70mg, 4 tabs in a dossing of once in a week.